1. Home
  2. RUM vs AMRX Comparison

RUM vs AMRX Comparison

Compare RUM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RUM
  • AMRX
  • Stock Information
  • Founded
  • RUM 2013
  • AMRX 2002
  • Country
  • RUM United States
  • AMRX United States
  • Employees
  • RUM N/A
  • AMRX N/A
  • Industry
  • RUM Computer Software: Prepackaged Software
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RUM Technology
  • AMRX Health Care
  • Exchange
  • RUM Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • RUM 2.6B
  • AMRX 2.4B
  • IPO Year
  • RUM N/A
  • AMRX N/A
  • Fundamental
  • Price
  • RUM $10.50
  • AMRX $7.83
  • Analyst Decision
  • RUM Buy
  • AMRX Strong Buy
  • Analyst Count
  • RUM 3
  • AMRX 5
  • Target Price
  • RUM $14.00
  • AMRX $10.00
  • AVG Volume (30 Days)
  • RUM 3.3M
  • AMRX 979.5K
  • Earning Date
  • RUM 03-26-2025
  • AMRX 02-28-2025
  • Dividend Yield
  • RUM N/A
  • AMRX N/A
  • EPS Growth
  • RUM N/A
  • AMRX N/A
  • EPS
  • RUM N/A
  • AMRX N/A
  • Revenue
  • RUM $85,651,775.00
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • RUM $18.52
  • AMRX $18.06
  • Revenue Next Year
  • RUM $21.18
  • AMRX $3.82
  • P/E Ratio
  • RUM N/A
  • AMRX N/A
  • Revenue Growth
  • RUM 6.36
  • AMRX 12.32
  • 52 Week Low
  • RUM $4.92
  • AMRX $5.01
  • 52 Week High
  • RUM $17.40
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • RUM 40.23
  • AMRX 42.03
  • Support Level
  • RUM $10.52
  • AMRX $7.66
  • Resistance Level
  • RUM $12.15
  • AMRX $7.95
  • Average True Range (ATR)
  • RUM 0.84
  • AMRX 0.21
  • MACD
  • RUM -0.25
  • AMRX -0.03
  • Stochastic Oscillator
  • RUM 1.19
  • AMRX 29.92

About RUM Rumble Inc.

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: